Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
CC transcript
SANTARUS INC (SNTS) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/07/2013 8-K Quarterly results
Docs: "Agreement and Plan of Merger, by and among Salix Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., Willow Acquisition Sub Corporation and Santarus, Inc",
"Tender and Support Agreement, by and among Salix Pharmaceuticals, Ltd., Willow Acquisition Sub Corporation and certain stockholders of Santarus, Inc",
"Amendment to Amended and Restated Bylaws of Santarus, Inc",
"SANTARUS REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS Total revenues of $98.8 million grew 81% over prior year period Non-GAAP adjusted earnings of $35.6 million were up 189% over prior year period Santarus cancels conference call previously scheduled for 5:00 p.m. Eastern Time today",
"SALIX PHARMACEUTICALS TO ACQUIRE SANTARUS Solidifies Position as Largest U.S. Gastroenterology-Focused Specialty Pharmaceutical Company Provides Salix with an Experienced Specialty Sales Force to Significantly Expand Gastrointestinal Product Sales Increases Commercial Presence in Gastroenterology, Hepatology and Colorectal Surgery Estimated 2013 Pro Forma Total Product Revenue of $1.3 Billion Greatly Increases Scale and Revenue Diversification Expected to be Immediately and Significantly Accretive Expected to Generate Strong EBITDA and Cash from Operations Leading to Rapid Debt Repayment"
08/06/2013 8-K Quarterly results
Docs: "SANTARUS REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS Total revenues of $89.4 million grew 89% over prior year period Raises 2013 financial outlook to include total revenues of $355 million to $360 million, and non-GAAP adjusted earnings of $97 million to $101 million"
05/06/2013 8-K Quarterly results
Docs: "SANTARUS REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS Total revenues increase 73% with significant increase in net income over prior year period Raises 2013 financial outlook to include total revenues of $330 million to $340 million, net income of $57 million to $64 million and non-GAAP adjusted earnings of $81 million to $91 million"
03/04/2013 8-K Quarterly results
Docs: "SANTARUS REPORTS FOURTH QUARTER AND FULL YEAR 2012 FINANCIAL RESULTS Company achieves record annual revenues of $218.0 million in 2012 2012 net income of $18.6 million and $0.27 diluted EPS more than triple prior year period"
08/07/2012 8-K Quarterly results
Docs: "SANTARUS REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS Total revenues of $47.2 million grew 77% over prior year period Net income of $3.4 million increased 27% over 2011 second quarter Affirms 2012 financial outlook including revenues of at least $200 million"
05/08/2012 8-K Quarterly results
Docs: "SANTARUS REPORTS FIRST QUARTER 2012 FINANCIAL RESULTS Total revenues of $45.9 million more than double compared with the prior year period Affirms 2012 financial outlook"
03/05/2012 8-K Quarterly results
Docs: "SANTARUS REPORTS FOURTH QUARTER AND FULL YEAR 2011 FINANCIAL RESULTS 2011 fourth quarter revenues of $42.6 million grew 65% over prior year period 2011 revenues totaled $118.8 million with net income of $4.7 million or $0.07 per diluted share"
11/07/2011 8-K Form 8-K - Current report
08/03/2011 8-K Quarterly results
Docs: "-"
05/04/2011 8-K Quarterly results
Docs: "SANTARUS REPORTS FIRST QUARTER 2011 FINANCIAL RESULTS Total revenues of $22.8 million; net loss of $0.5 million Conference call to begin at 5:00 p.m. Eastern time today"
03/03/2011 8-K Form 8-K - Current report
11/08/2010 8-K Form 8-K - Current report
05/06/2010 8-K Quarterly results
Docs: "SANTARUS REPORTS FIRST QUARTER 2010 FINANCIAL RESULTS Net income of $3.3 million or $0.05 per diluted share; Total revenues of $39.7 million Conference call to begin at 5:00 p.m. Eastern time today"
03/03/2010 8-K Quarterly results
Docs: "SANTARUS REPORTS FOURTH QUARTER AND FULL YEAR 2009 FINANCIAL RESULTS 2009 total revenues of $172.5 million, up 32% over prior year Net income of $32.1 million or $0.54 per diluted share Introduces 2010 financial outlook Conference call to begin at 5:00 p.m. Eastern time today"
08/03/2009 8-K Quarterly results
Docs: "SANTARUS REPORTS SECOND QUARTER 2009 FINANCIAL RESULTS Net income of $1.1 million or $0.02 per share; Total revenues of $35.8 million Full year 2009 guidance improved to breakeven or slight profit Conference call to begin at 5:00 p.m. Eastern time today"
05/06/2009 8-K Form 8-K -- Current report
03/05/2009 8-K Form 8-K -- Current report
11/03/2008 8-K Quarterly results
Docs: "SANTARUS REPORTS THIRD QUARTER 2008 FINANCIAL RESULTS Zegerid quarterly net product sales up 44% over prior year period Updating 2008 outlook, guiding to higher revenue and lower net loss Conference call to begin at 5:00 p.m. Eastern time today"
08/04/2008 8-K Quarterly results
Docs: "SANTARUS REPORTS SECOND QUARTER 2008 FINANCIAL RESULTS Second quarter revenues up 74% with increase in Zegerid product sales of 27% from prior year period Reports first profitable quarter Provides outlook for 2008 net loss Conference call to begin at 5:00 p.m. Eastern time today"
05/07/2008 8-K Quarterly results
Docs: "AMENDMENT NO. 1 TO",
"SANTARUS REPORTS FIRST QUARTER 2008 FINANCIAL RESULTS First quarter revenues up 29% and net loss reduced 54% from prior year period Updates financial outlook for 2008 Conference call to begin at 5:00 p.m. Eastern time today"
03/03/2008 8-K Quarterly results
Docs: "SANTARUS REPORTS FOURTH QUARTER AND FULL YEAR 2007 FINANCIAL RESULTS 2007 full year revenues of $94.4 million up 92% versus 2006 Provides financial outlook for 2008 Conference call to begin at 5:00 p.m. Eastern time today"
11/01/2007 8-K Quarterly results
Docs: "SANTARUS REPORTS THIRD QUARTER 2007 FINANCIAL RESULTS Third quarter revenues up 105% versus third quarter 2006; Outlook for estimated 2007 net loss reduced Conference call to begin at 5:00 p.m. Eastern time today"
08/06/2007 8-K Quarterly results
Docs: "SANTARUS REPORTS SECOND QUARTER 2007 FINANCIAL RESULTS Second quarter revenues up 121% versus second quarter 2006; Updates financial outlook for 2007 and 2008 Conference call to begin at 8:30 a.m. Eastern time today"
05/01/2007 8-K Quarterly results
Docs: "SANTARUS REPORTS FIRST QUARTER 2007 FINANCIAL RESULTS Conference call to begin at 5:00 p.m. Eastern time today"
03/05/2007 8-K Quarterly results
Docs: "SANTARUS REPORTS FOURTH QUARTER AND FULL YEAR 2006 FINANCIAL RESULTS Fourth quarter ZEGERID prescriptions up 248% versus 2005 fourth quarter Conference call to begin at 5:00 p.m. Eastern Time today"
11/07/2006 8-K Quarterly results
Docs: "SANTARUS REPORTS THIRD QUARTER 2006 FINANCIAL RESULTS Conference call to begin at 5:00 p.m. Eastern Time today"
08/08/2006 8-K Quarterly results
Docs: "SANTARUS REPORTS SECOND QUARTER 2006 FINANCIAL RESULTS Conference call to begin Today at 5:00 p.m. Eastern Time"
05/04/2006 8-K Quarterly results
Docs: "SANTARUS REPORTS FIRST QUARTER 2006 FINANCIAL RESULTS Conference call to begin at 5:00 p.m. Eastern Time today"
03/06/2006 8-K Quarterly results
Docs: "SANTARUS REPORTS FOURTH QUARTER AND FULL YEAR 2005 FINANCIAL RESULTS"
11/07/2005 8-K Quarterly results
Docs: "SANTARUS REPORTS THIRD QUARTER 2005 FINANCIAL RESULTS Conference call to begin at 5:00 p.m. Eastern Time today"
08/15/2005 8-K Quarterly results
Docs: "SANTARUS REPORTS SECOND QUARTER 2005 FINANCIAL RESULTS"
05/12/2005 8-K Quarterly results
Docs: "SANTARUS REPORTS FIRST QUARTER 2005 FINANCIAL RESULTS"
03/22/2005 8-K Quarterly results
Docs: "SANTARUS REPORTS FOURTH QUARTER AND FULL YEAR 2004 FINANCIAL RESULTS"
11/09/2004 8-K Quarterly results
Docs: "ZEGERID Powder for Oral Suspension 20mg"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy